C McLeod

Medicine · Health Sciences

17h-index1.0kcitations37works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(9), Cancer Genomics and Diagnostics(7), Lung Cancer Diagnosis and Treatment(6), Genetic factors in colorectal cancer(5), Radiomics and Machine Learning in Medical Imaging(5)

Publications37 total

Top-ups: The end of the NHS as we know it or one small step for patients?
2017
TCGA Pan-Cancer sample, expression, and mutation data for Project Cognoma
Figshare·2017Open Access
TCGA Pan-Cancer sample, expression, and mutation data for Project Cognoma
Figshare·2016Open Access
TCGA Pan-Cancer sample, expression, and mutation data for Project Cognoma
Figshare·2016Open Access
TCGA Pan-Cancer sample, expression, and mutation data for Project Cognoma
Figshare·2016Open Access
Evaluating the use of plerixafor in stem cell mobilisation – an economic analysis of the<scp>PHANTASTIC</scp>trial
Journal of Clinical Apheresis·2015· 14 cited
Plerixafor is cost‐effective compared to conventional chemotherapy for first‐line haematopoietic stem cell mobilization: Data from the PHANTASTIC trial
Journal of Clinical Apheresis·2015· 9 cited
Through a Glass Darkly: Economics and Personalised Medicine
PharmacoEconomics·2014· 18 cited
Variations in primary care prescribing: lessons to be learnt for GP commissioners
Primary Health Care Research & Development·2013· 1 citedOpen Access
Cetuximab nel carcinoma ricorrente e/o metastatico a cellule squamose della testa e del collo. Una valutazione di tecnologia singola del NICE
PharmacoEconomics Italian Research Articles·2011
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
Health Technology Assessment·2010· 13 citedOpen Access
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
Health Technology Assessment·2010· 19 citedOpen Access
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses
The Pharmacogenomics Journal·2010· 118 cited
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
Health Technology Assessment·2010· 29 citedOpen Access
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Health Technology Assessment·2010· 7 citedOpen Access
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
Health Technology Assessment·2010· 4 citedOpen Access
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Health Technology Assessment·2010· 26 citedOpen Access
Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
PharmacoEconomics·2010· 49 cited
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
Health Technology Assessment·2010· 64 citedOpen Access
Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
Health Technology Assessment·2009· 50 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Angela Boland(23), A Bagust(22), Y Dündar(22), Rumona Dickson(19), Nigel Fleeman(16), T Walley(12), J Greenhalgh(11), C Proudlove(8), Helen Davis(8), J Green(6), Jo Hockenhull(4), Alan Haycox(4), Richard Shaw(4), M Pearson(4), Rachel Houten(4), Daniel Himmelstein(4), Gregory P. Way(4), Casey S. Greene(4), Ruaraidh Hill(3), Munir Pirmohamed(3)